Antibiotic Resistance Market Segmented By Drug Class - Beta Lactum Antibiotic | Cephalosporins | Quinolones Antibiotics | Macrolide Antibiotics | Tetracyclines Oxazolidinones
Industry: Healthcare
Published Date: December-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 272
Report ID: PMRREP27895
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusion
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology
4.2. Product Adoption Analysis
4.3. Product USPs Analysis
4.4. Key Strategies Adopted by Manufactures
4.5. Pipeline Assessment
4.6. PESTLE Analysis
4.7. Porters Analysis
4.8. Regulatory Scenario
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Outlook
5.1.2. Global Biopharmaceutical Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Prevalence of Hospital-Acquired Infections
5.2.3. Key Regulations
5.2.4. Government Funding
5.2.5. Reimbursement Policy
5.2.6. Growing R&D Practices
5.2.7. Incidence of Bacterial Infections
5.2.8. New Product Launches and Approvals
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis
6.1. 2022 Market Scenario
6.2. COVID-19 and Impact Analysis
6.2.1. By Drug Class
6.2.2. By Pathogen
6.2.3. By Disease
6.2.4. By Mechanism of Action
6.2.5. By Distribution channel
6.2.6. By Region
7. Global Antibiotic Resistance Market Demand (in Value or Size in US$ Mn) Analysis 2015–2022 and Forecast, 2023–2033
7.1. Historical Market Value (US$ Mn) Analysis, 2015–2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, By Drug Class
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2015–2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2023–2033
8.3.1. Beta Lactum Antibiotic
8.3.2. Cephalosporins
8.3.3. Quinolones Antibiotics
8.3.4. Macrolide Antibiotics
8.3.5. Tetracyclines
8.3.6. Oxazolidinones
8.3.7. Others
8.4. Market Attractiveness Analysis By Drug Class
9. Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, By Pathogen
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Pathogen, 2015–2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Pathogen, 2023–2033
9.3.1. Staphylococcus aureus
9.3.2. Streptococcus pneumonia
9.3.3. Neisseria gonorrhoeae
9.3.4. Enterococcus faecium
9.3.5. Escherichia coli
9.3.6. Klebsiella Pneumonia
9.3.7. Shigella
9.3.8. Clostridium difficile
9.3.9. Others
9.4. Market Attractiveness Analysis By Pathogen
10. Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, By Disease
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Disease, 2015–2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2023–2033
10.3.1. Community Acquired Bacterial Pneumonia (CABP)
10.3.2. Hopitals Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
10.3.3. Complicated Urinary Tract Infections (CUTI)
10.3.4. Complicated Intra-Abdominal Infections (CIAI)
10.3.5. Blood Stream Infections (BSI)
10.3.6. Abdominal Infection and Diarohhea (Clostridium difficile infections (CDI) & Shigella)
10.3.7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
10.3.8. Drug Resistant Gonorrhoeae
10.4. Market Attractiveness Analysis By Disease
11. Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, By Mechanism of Action
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Mechanism of Action, 2015–2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mechanism of Action, 2023–2033
11.3.1. Cell Wall Synthesis Inhibitors
11.3.2. Protein Synthesis Inhibitors
11.3.3. DNA Synthesis Inhibitors
11.3.4. RNA Synthesis Inhibitors
11.3.5. Others
11.4. Market Attractiveness Analysis By Mechanism of Action
12. Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, By Distribution channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Distribution channel, 2015–2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution channel, 2023–2033
12.3.1. Hospitals Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Market Attractiveness Analysis By Distribution channel
13. Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2022
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023–2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023–2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023–2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Drug Class
14.3.3. By Pathogen
14.3.4. By Disease
14.3.5. By Mechanism of Action
14.3.6. Distribution channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug Class
14.4.3. By Pathogen
14.4.4. By Disease
14.4.5. By Mechanism of Action
14.4.6. Distribution channel
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. U.S. Antibiotic Resistance Market
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Drug Class
14.7.1.2.2. By Pathogen
14.7.1.2.3. By Disease
14.7.1.2.4. By Mechanism of Action
14.7.1.2.5. Distribution channel
14.7.2. Canada Antibiotic Resistance Market
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Drug Class
14.7.2.2.2. By Pathogen
14.7.2.2.3. By Disease
14.7.2.2.4. By Mechanism of Action
14.7.2.2.5. Distribution channel
15. Latin America Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023–2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023–2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Rest of Latin America
15.3.2. By Drug Class
15.3.3. By Pathogen
15.3.4. By Disease
15.3.5. By Mechanism of Action
15.3.6. Distribution channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug Class
15.4.3. By Pathogen
15.4.4. By Disease
15.4.5. By Mechanism of Action
15.4.6. Distribution channel
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. Brazil Antibiotic Resistance Market
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Drug Class
15.7.1.2.2. By Pathogen
15.7.1.2.3. By Disease
15.7.1.2.4. By Mechanism of Action
15.7.1.2.5. Distribution channel
15.7.2. Argentina Antibiotic Resistance Market
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Drug Class
15.7.2.2.2. By Pathogen
15.7.2.2.3. By Disease
15.7.2.2.4. By Mechanism of Action
15.7.2.2.5. Distribution channel
15.7.3. Mexico Antibiotic Resistance Market
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Drug Class
15.7.3.2.2. By Pathogen
15.7.3.2.3. By Disease
15.7.3.2.4. By Mechanism of Action
15.7.3.2.5. Distribution channel
16. Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023–2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023–2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Drug Class
16.3.3. By Pathogen
16.3.4. By Disease
16.3.5. By Mechanism of Action
16.3.6. Distribution channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug Class
16.4.3. By Pathogen
16.4.4. By Disease
16.4.5. By Mechanism of Action
16.4.6. Distribution channel
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. Germany Antibiotic Resistance Market
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Drug Class
16.7.1.2.2. By Pathogen
16.7.1.2.3. By Disease
16.7.1.2.4. By Mechanism of Action
16.7.1.2.5. Distribution channel
16.7.2. France Antibiotic Resistance Market
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Drug Class
16.7.2.2.2. By Pathogen
16.7.2.2.3. By Disease
16.7.2.2.4. By Mechanism of Action
16.7.2.2.5. Distribution channel
16.7.3. Italy Antibiotic Resistance Market
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast by Market Taxonomy
16.7.3.2.1. By Drug Class
16.7.3.2.2. By Pathogen
16.7.3.2.3. By Disease
16.7.3.2.4. By Mechanism of Action
16.7.3.2.5. Distribution channel
16.7.4. Spain Antibiotic Resistance Market
16.7.4.1. Introduction
16.7.4.2. Market Analysis and Forecast by Market Taxonomy
16.7.4.2.1. By Drug Class
16.7.4.2.2. By Pathogen
16.7.4.2.3. By Disease
16.7.4.2.4. By Mechanism of Action
16.7.4.2.5. Distribution channel
16.7.5. U.K. Antibiotic Resistance Market
16.7.5.1. Introduction
16.7.5.2. Market Analysis and Forecast by Market Taxonomy
16.7.5.2.1. By Drug Class
16.7.5.2.2. By Pathogen
16.7.5.2.3. By Disease
16.7.5.2.4. By Mechanism of Action
16.7.5.2.5. Distribution channel
16.7.6. BENELUX Union Antibiotic Resistance Market
16.7.6.1. Introduction
16.7.6.2. Market Analysis and Forecast by Market Taxonomy
16.7.6.2.1. By Drug Class
16.7.6.2.2. By Pathogen
16.7.6.2.3. By Disease
16.7.6.2.4. By Mechanism of Action
16.7.6.2.5. Distribution channel
16.7.7. Russia Antibiotic Resistance Market
16.7.7.1. Introduction
16.7.7.2. Market Analysis and Forecast by Market Taxonomy
16.7.7.2.1. By Drug Class
16.7.7.2.2. By Pathogen
16.7.7.2.3. By Disease
16.7.7.2.4. By Mechanism of Action
16.7.7.2.5. Distribution channel
17. South Asia Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023–2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023–2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Drug Class
17.3.3. By Pathogen
17.3.4. By Disease
17.3.5. By Mechanism of Action
17.3.6. Distribution channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Drug Class
17.4.3. By Pathogen
17.4.4. By Disease
17.4.5. By Mechanism of Action
17.4.6. Distribution channel
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. India Antibiotic Resistance Market
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Drug Class
17.7.1.2.2. By Pathogen
17.7.1.2.3. By Disease
17.7.1.2.4. By Mechanism of Action
17.7.1.2.5. Distribution channel
17.7.2. Indonesia Antibiotic Resistance Market
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Drug Class
17.7.2.2.2. By Pathogen
17.7.2.2.3. By Disease
17.7.2.2.4. By Mechanism of Action
17.7.2.2.5. Distribution channel
17.7.3. Malaysia Antibiotic Resistance Market
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Drug Class
17.7.3.2.2. By Pathogen
17.7.3.2.3. By Disease
17.7.3.2.4. By Mechanism of Action
17.7.3.2.5. Distribution channel
17.7.4. Thailand Antibiotic Resistance Market
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Drug Class
17.7.4.2.2. By Pathogen
17.7.4.2.3. By Disease
17.7.4.2.4. By Mechanism of Action
17.7.4.2.5. Distribution channel
18. East Asia Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023–2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023–2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Drug Class
18.3.3. By Pathogen
18.3.4. By Disease
18.3.5. By Mechanism of Action
18.3.6. Distribution channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Drug Class
18.4.3. By Pathogen
18.4.4. By Disease
18.4.5. By Mechanism of Action
18.4.6. Distribution channel
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. China Antibiotic Resistance Market
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Drug Class
18.7.1.2.2. By Pathogen
18.7.1.2.3. By Disease
18.7.1.2.4. By Mechanism of Action
18.7.1.2.5. Distribution channel
18.7.2. Japan Antibiotic Resistance Market
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Drug Class
18.7.2.2.2. By Pathogen
18.7.2.2.3. By Disease
18.7.2.2.4. By Mechanism of Action
18.7.2.2.5. Distribution channel
18.7.3. South Korea Antibiotic Resistance Market
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast by Market Taxonomy
18.7.3.2.1. By Drug Class
18.7.3.2.2. By Pathogen
18.7.3.2.3. By Disease
18.7.3.2.4. By Mechanism of Action
18.7.3.2.5. Distribution channel
19. Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023–2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023–2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Drug Class
19.3.3. By Pathogen
19.3.4. By Disease
19.3.5. By Mechanism of Action
19.3.6. Distribution channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Drug Class
19.4.3. By Pathogen
19.4.4. By Disease
19.4.5. By Mechanism of Action
19.4.6. Distribution channel
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
19.7. Country Level Analysis & Forecast
19.7.1. Australia Antibiotic Resistance Market
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast by Market Taxonomy
19.7.1.2.1. By Drug Class
19.7.1.2.2. By Pathogen
19.7.1.2.3. By Disease
19.7.1.2.4. By Mechanism of Action
19.7.1.2.5. Distribution channel
19.7.2. New Zealand Antibiotic Resistance Market
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast by Market Taxonomy
19.7.2.2.1. By Drug Class
19.7.2.2.2. By Pathogen
19.7.2.2.3. By Disease
19.7.2.2.4. By Mechanism of Action
19.7.2.2.5. Distribution channel
20. Middle East and Africa (MEA) Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023–2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023–2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. North Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Drug Class
20.3.3. By Pathogen
20.3.4. By Disease
20.3.5. By Mechanism of Action
20.3.6. Distribution channel
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Drug Class
20.4.3. By Pathogen
20.4.4. By Disease
20.4.5. By Mechanism of Action
20.4.6. Distribution channel
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
20.7. Country Level Analysis & Forecast
20.7.1. GCC Countries Antibiotic Resistance Market
20.7.1.1. Introduction
20.7.1.2. Market Analysis and Forecast by Market Taxonomy
20.7.1.2.1. By Drug Class
20.7.1.2.2. By Pathogen
20.7.1.2.3. By Disease
20.7.1.2.4. By Mechanism of Action
20.7.1.2.5. Distribution channel
20.7.2. Turkey Antibiotic Resistance Market
20.7.2.1. Introduction
20.7.2.2. Market Analysis and Forecast by Market Taxonomy
20.7.2.2.1. By Drug Class
20.7.2.2.2. By Pathogen
20.7.2.2.3. By Disease
20.7.2.2.4. By Mechanism of Action
20.7.2.2.5. Distribution channel
20.7.3. South Africa Antibiotic Resistance Market
20.7.3.1. Introduction
20.7.3.2. Market Analysis and Forecast by Market Taxonomy
20.7.3.2.1. By Drug Class
20.7.3.2.2. By Pathogen
20.7.3.2.3. By Disease
20.7.3.2.4. By Mechanism of Action
20.7.3.2.5. Distribution channel
20.7.4. North Africa Antibiotic Resistance Market
20.7.4.1. Introduction
20.7.4.2. Market Analysis and Forecast by Market Taxonomy
20.7.4.2.1. By Drug Class
20.7.4.2.2. By Pathogen
20.7.4.2.3. By Disease
20.7.4.2.4. By Mechanism of Action
20.7.4.2.5. Distribution channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Thermo Fisher Scientific, Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Development
22.3.1.5. SWOT Analysis
22.3.1.6. Strategy Overview
22.3.1.6.1. Marketing Strategy
22.3.1.6.2. Product Strategy
22.3.1.6.3. Channel Strategy
22.3.2. Merck KgaA
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Development
22.3.2.5. SWOT Analysis
22.3.2.6. Strategy Overview
22.3.2.6.1. Marketing Strategy
22.3.2.6.2. Product Strategy
22.3.2.6.3. Channel Strategy
22.3.3. Bio-Rad Laboratories, Inc.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Development
22.3.3.5. SWOT Analysis
22.3.3.6. Strategy Overview
22.3.3.6.1. Marketing Strategy
22.3.3.6.2. Product Strategy
22.3.3.6.3. Channel Strategy
22.3.4. Takara Bio, Inc.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Development
22.3.4.5. SWOT Analysis
22.3.4.6. Strategy Overview
22.3.4.6.1. Marketing Strategy
22.3.4.6.2. Product Strategy
22.3.4.6.3. Channel Strategy
22.3.5. QIAGEN N.V.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Development
22.3.5.5. SWOT Analysis
22.3.5.6. Strategy Overview
22.3.5.6.1. Marketing Strategy
22.3.5.6.2. Product Strategy
22.3.5.6.3. Channel Strategy
22.3.6. Pall Corporation
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Development
22.3.6.5. SWOT Analysis
22.3.6.6. Strategy Overview
22.3.6.6.1. Marketing Strategy
22.3.6.6.2. Product Strategy
22.3.6.6.3. Channel Strategy
22.3.7. Eppendorf Corporate
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Key Development
22.3.7.5. SWOT Analysis
22.3.7.6. Strategy Overview
22.3.7.6.1. Marketing Strategy
22.3.7.6.2. Product Strategy
22.3.7.6.3. Channel Strategy
22.3.8. Tarsons Products PVT. LTD.
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Key Development
22.3.8.5. SWOT Analysis
22.3.8.6. Strategy Overview
22.3.8.6.1. Marketing Strategy
22.3.8.6.2. Product Strategy
22.3.8.6.3. Channel Strategy
22.3.9. Applied Biological Materials Inc.
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Key Development
22.3.9.5. SWOT Analysis
22.3.9.6. Strategy Overview
22.3.9.6.1. Marketing Strategy
22.3.9.6.2. Product Strategy
22.3.9.6.3. Channel Strategy
22.3.10. Greiner AG
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. Key Development
22.3.10.5. SWOT Analysis
22.3.10.6. Strategy Overview
22.3.10.6.1. Marketing Strategy
22.3.10.6.2. Product Strategy
22.3.10.6.3. Channel Strategy
22.3.11. Brooks Life Sciences
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. Key Development
22.3.11.5. SWOT Analysis
22.3.11.6. Strategy Overview
22.3.11.6.1. Marketing Strategy
22.3.11.6.2. Product Strategy
22.3.11.6.3. Channel Strategy
22.3.12. Corning Incorporated
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Sales Footprint
22.3.12.4. Key Development
22.3.12.5. SWOT Analysis
22.3.12.6. Strategy Overview
22.3.12.6.1. Marketing Strategy
22.3.12.6.2. Product Strategy
22.3.12.6.3. Channel Strategy
22.3.13. Cytiva
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Sales Footprint
22.3.13.4. Key Development
22.3.13.5. SWOT Analysis
22.3.13.6. Strategy Overview
22.3.13.6.1. Marketing Strategy
22.3.13.6.2. Product Strategy
22.3.13.6.3. Channel Strategy
22.3.14. PerkinElmer
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Sales Footprint
22.3.14.4. Key Development
22.3.14.5. SWOT Analysis
22.3.14.6. Strategy Overview
22.3.14.6.1. Marketing Strategy
22.3.14.6.2. Product Strategy
22.3.14.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Drug Class
Table 02: Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Pathogen
Table 03: Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Disease
Table 04: Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Mechanism of Action
Table 05: Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Distribution channel
Table 06: Global Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Region
Table 07: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Country
Table 08: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Drug Class
Table 09: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Pathogen
Table 10: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Disease
Table 11: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Mechanism of Action
Table 12: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Distribution channel
Table 13: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Country
Table 14: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Drug Class
Table 15: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Pathogen
Table 16: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Disease
Table 17: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Mechanism of Action
Table 18: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Distribution channel
Table 19: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Country
Table 20: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Drug Class
Table 21: Europe Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Pathogen
Table 22: Europe Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Disease
Table 23: Europe Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Mechanism of Action
Table 24: Europe Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Distribution channel
Table 25: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Country
Table 26: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Drug Class
Table 27: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Pathogen
Table 28: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Disease
Table 29: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Mechanism of Action
Table 30: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Distribution channel
Table 31: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Country
Table 32: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Drug Class
Table 33: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Pathogen
Table 34: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Disease
Table 35: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Mechanism of Action
Table 36: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Distribution channel
Table 37: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Country
Table 38: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Drug Class
Table 39: Oceania Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Pathogen
Table 40: Oceania Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Disease
Table 41: Oceania Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Mechanism of Action
Table 42: Oceania Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Distribution channel
Table 43: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Country
Table 44: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2022 and Forecast 2023–2033, by Drug Class
Table 45: Middle East & Africa Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Pathogen
Table 46: Middle East & Africa Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Disease
Table 47: Middle East & Africa Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Mechanism of Action
Table 48: Middle East & Africa Antibiotic Resistance Market Analysis 2015–2022 and Forecast 2023–2033, by Distribution channel
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Global Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015–2022
Figure 02: Global Antibiotic Resistance Market Forecast & Y-o-Y Growth, 2023–2033
Figure 03: Global Antibiotic Resistance Market Absolute $ Opportunity (US$ Mn) Analysis, 2022–2033
Figure 04: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Drug Class
Figure 05: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022–2033, by Drug Class
Figure 06: Global Antibiotic Resistance Market Attractiveness Analysis 2023–2033, by Drug Class
Figure 07: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Pathogen
Figure 08: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022–2033, by Pathogen
Figure 09: Global Antibiotic Resistance Market Attractiveness Analysis 2023–2033, by Pathogen
Figure 10: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Disease
Figure 11: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022–2033, by Disease
Figure 12: Global Antibiotic Resistance Market Attractiveness Analysis 2023–2033, by Disease
Figure 13: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Mechanism of Action
Figure 14: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022–2033, by Mechanism of Action
Figure 15: Global Antibiotic Resistance Market Attractiveness Analysis 2023–2033, by Mechanism of Action
Figure 16: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Distribution channel
Figure 17: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022–2033, by Distribution channel
Figure 18: Global Antibiotic Resistance Market Attractiveness Analysis 2023–2033, by Distribution channel
Figure 19: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Region
Figure 20: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022–2033, by Region
Figure 21: Global Antibiotic Resistance Market Attractiveness Analysis 2023–2033, by Region
Figure 22: North America Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015–2022
Figure 23: North America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
Figure 24: North America Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
Figure 25: North America Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
Figure 26: North America Antibiotic Resistance Market Value Share, by Disease (2023 E)
Figure 27: North America Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
Figure 28: North America Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
Figure 29: North America Antibiotic Resistance Market Value Share, by Country (2023 E)
Figure 30: North America Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023–2033
Figure 31: North America Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023–2033
Figure 32: North America Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023–2033
Figure 33: North America Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023–2033
Figure 34: North America Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023–2033
Figure 35: North America Antibiotic Resistance Market Attractiveness Analysis by Country, 2023–2033
Figure 36: U.S. Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 37: Global Vs. U.S. Growth Comparison, 2022 - 2033
Figure 38: U.S. Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 39: U.S. Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 40: U.S. Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 41: U.S. Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 42: U.S. Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 43: Canada Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 44: Global Vs. Canada. Growth Comparison, 2022 - 2033
Figure 45: Canada Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 46: Canada Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 47: Canada Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 48: Canada Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 49: Canada Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 50: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015–2022
Figure 51: Latin America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
Figure 52: Latin America Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
Figure 53: Latin America Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
Figure 54: Latin America Antibiotic Resistance Market Value Share, by Disease (2023 E)
Figure 55: Latin America Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
Figure 56: Latin America Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
Figure 57: Latin America Antibiotic Resistance Market Value Share, by Country (2023 E)
Figure 58: Latin America Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023–2033
Figure 59: Latin America Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023–2033
Figure 60: Latin America Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023–2033
Figure 61: Latin America Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023–2033
Figure 62: Latin America Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023–2033
Figure 63: Latin America Antibiotic Resistance Market Attractiveness Analysis by Country, 2023–2033
Figure 64: Mexico Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 65: Global Vs Mexico Growth Comparison, 2022 - 2033
Figure 66: Mexico Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 67: Mexico Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 68: Mexico Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 69: Mexico Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 70: Mexico Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 71: Brazil Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 72: Global Vs. Brazil. Growth Comparison, 2022 - 2033
Figure 73: Brazil Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 74: Brazil Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 75: Brazil Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 76: Brazil Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 77: Brazil Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 78: Argentina Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 79: Global Vs Argentina Growth Comparison, 2022 - 2033
Figure 80: Argentina Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 81: Argentina Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 82: Argentina Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 83: Argentina Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 84: Argentina Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 85: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015–2022
Figure 86: Europe Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
Figure 87: Europe Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
Figure 88: Europe Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
Figure 89: Europe Antibiotic Resistance Market Value Share, by Disease (2023 E)
Figure 90: Europe Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
Figure 91: Europe Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
Figure 92: Europe Antibiotic Resistance Market Value Share, by Country (2023 E)
Figure 93: Europe Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023–2033
Figure 94: Europe Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023–2033
Figure 95: Europe Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023–2033
Figure 96: Europe Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023–2033
Figure 97: Europe Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023–2033
Figure 98: Europe Antibiotic Resistance Market Attractiveness Analysis by Country, 2023–2033
Figure 99: UK Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 100: Global Vs. UK Growth Comparison, 2022 - 2033
Figure 101: UK Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 102: UK Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 103: UK Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 104: UK Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 105: UK Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 106: Germany Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 107: Global Vs. Germany Growth Comparison, 2022 - 2033
Figure 108: Germany Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 109: Germany Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 110: Germany Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 111: Germany Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 112: Germany Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 113: Italy Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 114: Global Vs. Italy Growth Comparison, 2022 - 2033
Figure 115: Italy Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 116: Italy Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 117: Italy Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 118: Italy Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 119: Italy Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 120: France Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 121: Global Vs France Growth Comparison, 2022 - 2033
Figure 122: France Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 123: France Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 124: France Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 125: France Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 126: France Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 127: Spain Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 128: Global Vs Spain Growth Comparison, 2022 - 2033
Figure 129: Spain Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 130: Spain Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 131: Spain Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 132: Spain Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 133: Spain Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 134: Russia Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 135: Global Vs Russia Growth Comparison, 2022 - 2033
Figure 136: Russia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 137: Russia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 138: Russia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 139: Russia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 140: Russia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 141: BENELUX Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 142: Global Vs BENELUX Growth Comparison, 2022 - 2033
Figure 143: BENELUX Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 144: BENELUX Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 145: BENELUX Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 146: BENELUX Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 147: BENELUX Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 148: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015–2022
Figure 149: East Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
Figure 150: East Asia Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
Figure 151: East Asia Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
Figure 152: East Asia Antibiotic Resistance Market Value Share, by Disease (2023 E)
Figure 153: East Asia Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
Figure 154: East Asia Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
Figure 155: East Asia Antibiotic Resistance Market Value Share, by Country (2023 E)
Figure 156: East Asia Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023–2033
Figure 157: East Asia Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023–2033
Figure 158: East Asia Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023–2033
Figure 159: East Asia Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023–2033
Figure 160: East Asia Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023–2033
Figure 161: East Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2023–2033
Figure 162: China Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 163: Global Vs. China Growth Comparison, 2022 - 2033
Figure 164: China Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 165: China Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 166: China Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 167: China Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 168: China Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 169: Japan Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 170: Global Vs. Japan Growth Comparison, 2022 - 2033
Figure 171: Japan Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 172: Japan Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 173: Japan Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 174: Japan Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 175: Japan Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 176: South Korea Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 177: Global Vs South Korea Growth Comparison, 2022 - 2033
Figure 178: South Korea Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 179: South Korea Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 180: South Korea Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 181: South Korea Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 182: South Korea Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 183: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015–2022
Figure 184: South Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
Figure 185: South Asia Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
Figure 186: South Asia Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
Figure 187: South Asia Antibiotic Resistance Market Value Share, by Disease (2023 E)
Figure 188: South Asia Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
Figure 189: South Asia Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
Figure 190: South Asia Antibiotic Resistance Market Value Share, by Country (2023 E)
Figure 191: South Asia Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023–2033
Figure 192: South Asia Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023–2033
Figure 193: South Asia Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023–2033
Figure 194: South Asia Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023–2033
Figure 195: South Asia Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023–2033
Figure 196: South Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2023–2033
Figure 197: India Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 198: Global Vs. India Growth Comparison, 2022 - 2033
Figure 199: India Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 200: India Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 201: India Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 202: India Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 203: India Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 204: Indonesia Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 205: Global Vs. Indonesia Growth Comparison, 2022 - 2033
Figure 206: Indonesia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 207: Indonesia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 208: Indonesia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 209: Indonesia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 210: Indonesia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 211: Malaysia Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 212: Global Vs. Malaysia Growth Comparison, 2022 - 2033
Figure 213: Malaysia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 214: Malaysia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 215: Malaysia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 216: Malaysia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 217: Malaysia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 218: Thailand Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 219: Global Vs. Thailand Growth Comparison, 2022 - 2033
Figure 220: Thailand Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 221: Thailand Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 222: Thailand Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 223: Thailand Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 224: Thailand Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 225: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015–2022
Figure 226: Oceania Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
Figure 227: Oceania Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
Figure 228: Oceania Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
Figure 229: Oceania Antibiotic Resistance Market Value Share, by Disease (2023 E)
Figure 230: Oceania Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
Figure 231: Oceania Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
Figure 232: Oceania Antibiotic Resistance Market Value Share, by Country (2023 E)
Figure 233: Oceania Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023–2033
Figure 234: Oceania Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023–2033
Figure 235: Oceania Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023–2033
Figure 236: Oceania Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023–2033
Figure 237: Oceania Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023–2033
Figure 238: Oceania Antibiotic Resistance Market Attractiveness Analysis by Country, 2023–2033
Figure 239: Australia Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 240: Global Vs. Australia Growth Comparison, 2022 - 2033
Figure 241: Australia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 242: Australia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 243: Australia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 244: Australia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 245: Australia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 246: New Zealand Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 247: Global Vs New Zealand Growth Comparison, 2022 - 2033
Figure 248: New Zealand Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 249: New Zealand Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 250: New Zealand Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 251: New Zealand Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 252: New Zealand Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 253: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015–2022
Figure 254: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
Figure 255: Middle East & Africa Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
Figure 256: Middle East & Africa Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
Figure 257: Middle East & Africa Antibiotic Resistance Market Value Share, by Disease (2023 E)
Figure 258: Middle East & Africa Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
Figure 259: Middle East & Africa Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
Figure 260: Middle East & Africa Antibiotic Resistance Market Value Share, by Country (2023 E)
Figure 261: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023–2033
Figure 262: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023–2033
Figure 263: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023–2033
Figure 264: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023–2033
Figure 265: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023–2033
Figure 266: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Country, 2023–2033
Figure 267: GCC Countries Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 268: Global Vs GCC Countries Growth Comparison, 2022 - 2033
Figure 269: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 270: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 271: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 272: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 273: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 274: Turkey Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 275: Global Vs. Turkey Growth Comparison, 2022 - 2033
Figure 276: Turkey Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 277: Turkey Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 278: Turkey Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 279: Turkey Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 280: Turkey Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 281: South Africa Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 282: Global Vs. South Africa Growth Comparison, 2022 - 2033
Figure 283: South Africa Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 284: South Africa Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 285: South Africa Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 286: South Africa Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 287: South Africa Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
Figure 288: North Africa Antibiotic Resistance Market Value Proportion Analysis, 2022
Figure 289: Global Vs North Africa Growth Comparison, 2022 - 2033
Figure 290: North Africa Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
Figure 291: North Africa Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
Figure 292: North Africa Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
Figure 293: North Africa Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
Figure 294: North Africa Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
